Main > A1. CORP. INDEX. I-Im > ImmunoGen/P C2
ImmunoGen/P C2's subsections
2000. 07.31.2000. (Focus)
2003. 08.06.2003. (Oncology JV)
2005. 09.05.2005. (Sanofi Aventis)
2005. 10.17.2005. (Diosynth Bio)
2006. 09.25.2006. Exec VP Science
2007. 12.09.2007. SAR3419
2008. 01.03.2008. IMGN388
2008. 02.01.2008. (MileStone Earn.)
2008. 12.08.2008. IMGN901
2009. 05.30.2009. T-DM1
2009. 06.11.2009. IMGN242
2010. 10.11.2010. Novartis
2011. 12.20.2011. Eli Lilly
2012. 01.30.2012. BoD
2012. 04.17.2012. Onco.>IMGN853
2012. 04.17.2012. Onco.>NHL
2012. 11.26.2012. CDO
2013. 10.22. Onco.>ADC Tech.>IGN
2013. 11.05. Onco.>Lung C>SCLC
2013. 11.11. Novartis
2013. 11.20. Onco.>Breast C.
2015. 03.30. Royalty Transaction
2017. 05.30. Sanofi
2017. 08.29. Jazz Pharma.
2022. 02.15. Eli Lilly
2022. 11.14. FDA Accelerated OK
2023. 11.30. Acq. By AbbVie
2024. 02.12. Acq. By AbbVie
Web-Site
ImmunoGen/P C2's products
This section has no products